Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
11°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Schrodinger Inc
(NQ:
SDGR
)
22.28
+1.44 (+6.91%)
Streaming Delayed Price
Updated: 11:06 AM EST, Nov 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Schrodinger Inc
< Previous
1
2
3
4
5
Next >
Schrödinger to Present at Piper Sandler 36th Annual Healthcare Conference
November 20, 2024
From
Schrödinger
Via
Business Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
November 19, 2024
From
Schrödinger
Via
Business Wire
Schrödinger Broadens and Accelerates Predictive Toxicology Initiative
November 18, 2024
From
Schrödinger
Via
Business Wire
Schrödinger Reports Third Quarter 2024 Financial Results
November 12, 2024
From
Schrödinger
Via
Business Wire
Schrödinger Announces Multi-Target Collaboration and Expanded Software Licensing Agreement with Novartis
November 12, 2024
From
Schrödinger
Via
Business Wire
Schrödinger to Present at Jefferies London Healthcare Conference
November 04, 2024
From
Schrödinger
Via
Business Wire
Schrödinger to Announce Third Quarter 2024 Financial Results on November 12
October 31, 2024
From
Schrödinger
Via
Business Wire
Schrödinger Presents SGR-3515 Preclinical Data at 2024 EORTC-NCI-AACR Symposium
October 23, 2024
From
Schrödinger
Via
Business Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
October 17, 2024
From
Schrödinger
Via
Business Wire
Schrödinger to Present New Preclinical SGR-3515 and PRMT5-MTA Data at 2024 EORTC-NCI-AACR Symposium
October 09, 2024
From
Schrödinger
Via
Business Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
September 18, 2024
From
Schrödinger
Via
Business Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
August 16, 2024
From
Schrödinger
Via
Business Wire
Schrödinger to Present at Morgan Stanley Global Healthcare Conference
August 14, 2024
From
Schrödinger
Via
Business Wire
Schrödinger Reports Strong Second Quarter 2024 Financial Results
July 31, 2024
From
Schrödinger
Via
Business Wire
Schrödinger Launches Initiative to Significantly Expand Application of Computational Tools for Predictive Toxicology
July 26, 2024
From
Schrödinger
Via
Business Wire
Schrödinger to Announce Second Quarter 2024 Financial Results on July 31
July 17, 2024
From
Schrödinger
Via
Business Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
July 16, 2024
From
Schrödinger
Via
Business Wire
Simulations Plus Stock Drops 15% Despite EPS Beat
July 05, 2024
Simulations Plus fell 15% the day after its earnings release despite beating EPS estimates due to lower margins and lower full-year guidance.
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
June 14, 2024
From
Schrödinger
Via
Business Wire
Schrödinger to Present at Jefferies Global Healthcare Conference
May 22, 2024
From
Schrödinger
Via
Business Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
May 17, 2024
From
Schrödinger
Via
Business Wire
Schrödinger Reports First Quarter 2024 Financial Results
May 01, 2024
From
Schrödinger
Via
Business Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
April 18, 2024
From
Schrödinger
Via
Business Wire
Schrödinger to Announce First Quarter 2024 Financial Results on May 1
April 10, 2024
From
Schrödinger
Via
Business Wire
Schrödinger Highlights Discovery of SGR-1505, Clinical-Stage MALT1 Inhibitor, at American Chemical Society National Meeting
March 20, 2024
From
Schrödinger
Via
Business Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
March 19, 2024
From
Schrödinger
Via
Business Wire
Schrödinger Reports Strong Fourth Quarter and Full-Year 2023 Financial Results
February 28, 2024
From
Schrödinger
Via
Business Wire
Schrödinger to Participate in Upcoming Investor Conferences
February 20, 2024
From
Schrödinger
Via
Business Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
February 16, 2024
From
Schrödinger
Via
Business Wire
Schrödinger to Announce Fourth Quarter and Full-Year 2023 Financial Results on February 28
February 14, 2024
From
Schrödinger
Via
Business Wire
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.